James R. Lisbakken

Jim Lisbakken, a partner and Co-Chair of the firm's Technology Transactions & Privacy practice, focuses on business transactions, licensing, and joint ventures and corporations specifically in the life sciences and technology industries. He has experience serving as outside general counsel to boards of directors of public and private companies, and has advised clients on numerous strategic alliances and technology agreements with Eli Lilly, GlaxoSmithKline, Serono, Johnson & Johnson, Abbott Laboratories and other international life sciences companies. Jim also has experience with financing transactions, acquisitions and spin-outs.

Professional Recognition

• Named the Best Lawyers’ 2012 Seattle Biotechnology Law Lawyer of the Year
• Listed in Washington Law & Politics, "Washington's Super Lawyers," 2005 - 2011
• Listed in The Best Lawyers in America

Professional Leadership

• American Bar Association, Business and Intellectual Property Sections
• Washington State Bar Association, Business and Intellectual Property Sections
• Licensing Executives Society
• Northwest Biotechnology Series, Organizing Committee
• Washington Biotechnology and Biomedical Association, founding Board of Directors

Related Employment

• Genetic Systems Corporation, Seattle, WA, Executive Vice President, General Counsel and Director, 1983 - 1985
• Westinghouse Nuclear Power Divisions, 1967 - 1970